Xanodyne Pharmaceuticals Inc

-

Company Reg D Offering

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Xanodyne Pharmaceuticals Inc
Firm
Fund #
CIK #0001335480
Sale2009-05-15 (87.8 M Offered, 87.8 M Sold)
Fund
Phone8593717581
AddressOne Riverfront Place
Newport, 41071
Source [EDGAR]
Amount Raised ($M)
907254361802008201020132016
Company Details
Director
Custodian
Auditor
Marketer
Broker
Jurisdiction
Form D Offering
Filed2009-10-30 (D/A)
Exemption506
DurationOne year or less
Commission$1,108,768
RevenueDecline to Disclose
DirectorsRole2011 - 2026
Rita O'Connor Executive Officer
Vaughan Kailian Director
Stephen St Peter Director
Stephen Stamp Executive Officer
Timothy Arendt Executive Officer
Steven St Peter Director
Thomas Jennings Executive Officer
Craig Tooman Director
Natasha Giordano Executive Officer
James Shannon Director
Peter Wentworth Executive Officer
Dennis Purcell Director
Kevin Anderson Executive Officer
Rolf Classon Director
Michael Valentino Executive Officer
Gary Shangold Executive Officer
Daniel Docherty Executive Officer
Vaughn Kailian Director
Patrick Enright Director
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com